Details

DSEN Abstract: Dipeptidyl peptidase-4 (DPP-4) inhibitors were superior to placebo but not statistically different than intermediate-acting insulin in adults with type 2 diabetes: Results of a network meta-analysis - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Apr 10, 2025 · edition #2
Timestamp
2025-04-10T11:06:47.055Z
Language
en
ID
134130
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview